134 related articles for article (PubMed ID: 25231171)
1. Transmission of LDLR mutation from donor through liver transplantation resulting in hypercholesterolemia in the recipient.
Nikkilä K; Åberg F; Isoniemi H
Am J Transplant; 2014 Dec; 14(12):2898-902. PubMed ID: 25231171
[TBL] [Abstract][Full Text] [Related]
2. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
3. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.
Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW
Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182
[TBL] [Abstract][Full Text] [Related]
5. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia.
Santos PC; Morgan AC; Jannes CE; Turolla L; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2014 Mar; 233(1):206-10. PubMed ID: 24529145
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
8. Hyperlipidemia patients carrying LDLR splicing mutation c.1187-2A>G respond favorably to rosuvastatin and PCSK9 inhibitor evolocumab.
Zhang X; Liu Q; Zhang H; Tan C; Zhu Q; Chen S; Du Y; Yang H; Li Q; Xu C; Wu C; Wang QK
Mol Genet Genomics; 2022 May; 297(3):833-841. PubMed ID: 35441343
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
10. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.
Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Inoue T; Mori M; Tada H; Nakanishi C; Yagi K; Yamagishi M; Ueda K; Takegoshi T; Miyamoto S; Inazu A; Koizumi J;
Atherosclerosis; 2014 Sep; 236(1):54-61. PubMed ID: 25014035
[TBL] [Abstract][Full Text] [Related]
11. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
12. Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia.
Jones C; Hammer RE; Li WP; Cohen JC; Hobbs HH; Herz J
J Biol Chem; 2003 Aug; 278(31):29024-30. PubMed ID: 12746448
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.
Lambert G; Petrides F; Chatelais M; Blom DJ; Choque B; Tabet F; Wong G; Rye KA; Hooper AJ; Burnett JR; Barter PJ; Marais AD
J Am Coll Cardiol; 2014 Jun; 63(22):2365-73. PubMed ID: 24632287
[TBL] [Abstract][Full Text] [Related]
14. Impaired adult hippocampal neurogenesis in a mouse model of familial hypercholesterolemia: A role for the LDL receptor and cholesterol metabolism in adult neural precursor cells.
Engel DF; Grzyb AN; de Oliveira J; Pötzsch A; Walker TL; Brocardo PS; Kempermann G; de Bem AF
Mol Metab; 2019 Dec; 30():1-15. PubMed ID: 31767163
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).
Schaefer JR; Kurt B; Sattler A; Klaus G; Soufi M
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):2-6. PubMed ID: 22528129
[TBL] [Abstract][Full Text] [Related]
17. A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing.
Tada H; Hosomichi K; Okada H; Kawashiri MA; Nohara A; Inazu A; Tomizawa S; Tajima A; Mabuchi H; Hayashi K
Clin Chim Acta; 2016 Jan; 453():194-6. PubMed ID: 26721317
[TBL] [Abstract][Full Text] [Related]
18. Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia.
Hartgers ML; Defesche JC; Langslet G; Hopkins PN; Kastelein JJP; Baccara-Dinet MT; Seiz W; Hamon S; Banerjee P; Stefanutti C
J Clin Lipidol; 2018; 12(2):390-396.e8. PubMed ID: 29396260
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
